Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Family Practice · SUFFOLK, VA · NPI 1174183164
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 734 | 238 |
| Amlodipine Besylate | Amlodipine Besylate | 584 | 180 |
| Losartan Potassium | Losartan Potassium | 411 | 125 |
| Omeprazole | Omeprazole | 381 | 124 |
| Levothyroxine Sodium | Levothyroxine Sodium | 281 | 84 |
| Gabapentin | Gabapentin | 276 | 101 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 246 | 75 |
| Lisinopril | Lisinopril | 244 | 75 |
| Metformin Hcl Er | Metformin Hcl | 235 | 77 |
| Simvastatin | Simvastatin | 233 | 77 |
| Hydrochlorothiazide | Hydrochlorothiazide | 206 | 72 |
| Tamsulosin Hcl | Tamsulosin Hcl | 181 | 59 |
| Metformin Hcl | Metformin Hcl | 171 | 56 |
| Metoprolol Succinate | Metoprolol Succinate | 160 | 49 |
| Pravastatin Sodium | Pravastatin Sodium | 148 | 46 |
| Fluticasone Propionate | Fluticasone Propionate | 146 | 57 |
| Carvedilol | Carvedilol | 143 | 42 |
| Furosemide | Furosemide | 141 | 50 |
| Trazodone Hcl | Trazodone Hcl | 141 | 45 |
| Montelukast Sodium | Montelukast Sodium | 133 | 37 |
| Sertraline Hcl | Sertraline Hcl | 129 | 40 |
| Escitalopram Oxalate | Escitalopram Oxalate | 127 | 37 |
| Allopurinol | Allopurinol | 125 | 37 |
| Duloxetine Hcl | Duloxetine Hcl | 113 | 37 |
| Pantoprazole Sodium | Pantoprazole Sodium | 112 | 37 |
| Metoprolol Tartrate | Metoprolol Tartrate | 109 | 32 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 108 | 31 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 104 | 39 |
| Potassium Chloride | Potassium Chloride | 99 | 32 |
| Glimepiride | Glimepiride | 89 | 28 |
| Fluoxetine Hcl | Fluoxetine Hcl | 87 | 31 |
| Warfarin Sodium | Warfarin Sodium | 83 | 23 |
| Tramadol Hcl | Tramadol Hcl | 81 | 30 |
| Famotidine | Famotidine | 80 | 27 |
| Meloxicam | Meloxicam | 76 | 26 |
| Ozempic | Semaglutide | 75 | 22 |
| Eliquis | Apixaban | 71 | 22 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 70 | 21 |
| Bupropion Xl | Bupropion Hcl | 68 | 25 |
| Ezetimibe | Ezetimibe | 67 | 21 |
| Xarelto | Rivaroxaban | 66 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 65 | 29 |
| Mirtazapine | Mirtazapine | 65 | 27 |
| Diclofenac Sodium | Diclofenac Sodium | 57 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 56 | 19 |
| Jardiance | Empagliflozin | 56 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 56 | 18 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 56 | 38 |
| Lorazepam | Lorazepam | 55 | 17 |
| Spironolactone | Spironolactone | 54 | 19 |
| Trulicity | Dulaglutide | 53 | 12 |
| Atenolol | Atenolol | 52 | 17 |
| Celecoxib | Celecoxib | 49 | 17 |
| Fenofibrate | Fenofibrate Nanocrystallized | 49 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 47 | 14 |
| Buspirone Hcl | Buspirone Hcl | 46 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 45 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 42 | 11 |
| Donepezil Hcl | Donepezil Hcl | 41 | 14 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 41 | suppressed |
| Pregabalin | Pregabalin | 41 | 11 |
| Nystatin | Nystatin | 40 | 18 |
| Alendronate Sodium | Alendronate Sodium | 39 | 13 |
| Memantine Hcl | Memantine Hcl | 39 | 12 |
| Alprazolam | Alprazolam | 37 | 14 |
| Chlorthalidone | Chlorthalidone | 37 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 37 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 36 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 35 | 12 |
| Synthroid | Levothyroxine Sodium | 35 | 15 |
| Meclizine Hcl | Meclizine Hcl | 34 | 20 |
| Doxazosin Mesylate | Doxazosin Mesylate | 33 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 32 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 30 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 30 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 29 | suppressed |
| Mounjaro | Tirzepatide | 27 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 27 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 26 | 12 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 26 | 24 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 26 | suppressed |
| Glipizide | Glipizide | 25 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 25 | suppressed |
| Prednisone | Prednisone | 24 | 22 |
| Valsartan | Valsartan | 23 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 23 | suppressed |
| Baclofen | Baclofen | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 22 | suppressed |
| Naproxen | Naproxen | 22 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Telmisartan | Telmisartan | 22 | suppressed |
| Bumetanide | Bumetanide | 21 | suppressed |
| Fenofibrate | Fenofibrate | 21 | suppressed |
| Glipizide Er | Glipizide | 21 | suppressed |
| Indapamide | Indapamide | 21 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 20 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 19 | suppressed |
| Gemfibrozil | Gemfibrozil | 19 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 19 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 19 | suppressed |
| Azithromycin | Azithromycin | 18 | 18 |
| Januvia | Sitagliptin Phosphate | 18 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 18 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 17 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Dutasteride | Dutasteride | 17 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Ondansetron Odt | Ondansetron | 17 | suppressed |
| Sotalol | Sotalol Hcl | 17 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Finasteride | Finasteride | 16 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 16 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 16 | suppressed |
| Ibu | Ibuprofen | 15 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 15 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Nifedipine Er | Nifedipine | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 14 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 14 | suppressed |
| Klor-Con M20 | Potassium Chloride | 14 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | 12 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 12 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error